J Menopausal Med.
2021 Aug;27(2):49-57. 10.6118/jmm.20038.
Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women
- Affiliations
-
- 1Department of Obstetrics and Gynecology, College of Medicine, Pusan National University, Busan, Korea
- 2Department of Obstetrics and Gynecology, College of Medicine, Korea University, Seoul, Korea
- 3Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea
- 4Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea
- 5Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea
- KMID: 2519413
- DOI: http://doi.org/10.6118/jmm.20038
Abstract
- The levonorgestrel-releasing intrauterine system (LNG-IUS) is a highly effective contraceptive method that has several noncontraceptive benefits. It has been used in various gynecological conditions, such as heavy menstrual bleeding, dysmenorrhea, and endometrial hyperplasia. During the perimenopausal period, hormonal fluctuations occur, and there is a high tendency for the development of several benign gynecologic diseases. Therefore, the use of LNG-IUS in perimenopausal women might be more beneficial than in women belonging to other age groups. Moreover, the insertion of LNG-IUS during the perimenopausal period could confer endometrial protection during estrogen replacement therapy. In this review, we discuss the use of LNG-IUS in perimenopausal women.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Effectiveness of Levonorgestrel Releasing Intrauterine System in Perimenopausal Women with Heavy Menstrual Bleeding: A Prospective Study at a Teaching Hospital in India
- Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
- Clinical applications of levonorgestrel-releasing intrauterine system (LNG-IUS: Mirena(R)) in gynecologic diseases
- LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trial
- Therapeutic efficacy of Mirena in gynecologic disease
